JYMed yapatsidwa chilolezo cha ku Europe chifukwa cha njira yake yopangira Liraglutide. Chofunikira ichi chikuwonetsa utsogoleri wathu wopitilira mu peptide R&D ndi IP. Patent iyi ikuyimira njira yatsopano yopangira liraglutide, zomwe sizimangotsimikizira zokolola zokhazikika komanso zimachepetsa kwambiri mapangidwe a zonyansa zamtundu [D-Thr ^ 5] -Liraglutide, zomwe zimafanana kwambiri ndi zomwe mukufuna. Kusintha kumeneku kumakulitsa mtundu wazinthu zonse.

Kupezeka kwa setifiketi yaku Europe iyi kukuwonetsa luso la R&D la kampaniyo, ndikulimbitsanso zabwino zake zaukadaulo. Zimathandizira kulimbikitsa mpikisano wapakatikati wa JYMed ndikukulitsa kupezeka kwake m'misika yapadziko lonse lapansi. Kuonjezera apo, imalimbikitsa ubwino wa kampaniyo, ndikuthandiza kusunga ndi kupititsa patsogolo mpikisano wa msika wapadziko lonse.

Hubei JXBio Pharmaceutical Co., Ltd, kampani ya Shenzhen JYMed Technology Co., Ltd, yalandira posachedwa Chidziwitso Chovomerezeka Msika cha Oxytocin Active Pharmaceutical Ingredient (API) choperekedwa ndi National Medical Products Administration (NMPA) yaku China.

Chivomerezochi chikusonyeza kuti JXBio's oxytocin API ikukwaniritsa zofunikira zaukadaulo zomwe zimakhazikitsidwa ndi dongosolo lowunika mankhwala mdziko muno. Ndichidziwitso chofunikira kwambiri kwa kampani, kupititsa patsogolo mbiri yake yazinthu ndikupereka maziko olimba pakukulitsa msika mu gawo la oxytocin.
ZA JYMED
JYMed ndi kampani yaukadaulo yaukadaulo ya biopharmaceutical yomwe imagwira ntchito pa kafukufuku wodziyimira pawokha, chitukuko, kupanga, ndi kugulitsa zinthu zopangidwa ndi peptide, komanso ntchito zopanga makontrakiti ndi mabungwe opanga (CDMO). Kampaniyo yadzipereka kupereka ma API apamwamba kwambiri a peptide ndi mayankho makonda kwa makasitomala apadziko lonse lapansi. Zogulitsa zake zimaphatikizapo ma API angapo a peptide, okhala ndi zinthu zoyambira monga Semaglutide ndi Terlipressin atamaliza kale zolemba za US FDA DMF.

Kampani yake, Hubei JXBio Pharmaceutical Co., Ltd., imagwiritsa ntchito mizere yapamwamba ya peptide API yomwe imagwirizana ndi mfundo za cGMP zokhazikitsidwa ndi US FDA, European EMA, ndi NMPA ya China. Malowa ali ndi mizere 10 yayikulu komanso yoyendetsa ndege ndipo yakhazikitsa dongosolo lokhazikika lazamankhwala (QMS) komanso dongosolo loyang'anira zaumoyo ndi chitetezo (EHS). Izi zimawonetsetsa kuti ntchito yonse, kuyambira pa R&D mpaka kupanga, ikukwaniritsa miyezo yapamwamba kwambiri padziko lonse lapansi. Kampaniyo yadutsa bwino pakuwunika kwa GMP kochitidwa ndi US FDA ndi NMPA yaku China ndipo yadziwika ndi makampani otsogola padziko lonse lapansi chifukwa cha kayendetsedwe kabwino ka EHS, kuwonetsa kudzipereka kwake pakusamalira bwino, chitetezo, komanso udindo wa chilengedwe.

Magawo a Bizinesi Yapakati:Kulembetsa ndi kutsatira API ya peptide yapadziko lonse lapansi,Chowona Zanyama ndi zodzikongoletsera peptides,Ntchito zamtundu wa peptide, kuphatikiza mayankho a CRO, CMO, ndi OEM,Peptide-drug conjugates (PDCs), kuphatikiza peptide-radionuclide, peptide-yaing'ono molekyulu, peptide-protein, ndi peptide-RNA therapeutics..

ZOPHUNZITSA ZABWINO

Kuti mumve zambiri pazogulitsa zathu, lemberani.

Mafunso a Global API ndi Zodzikongoletsera: Tel No.: +86-15013529272;

API Registration & CDMO Services (msika wa USA EU）+ 86-15818682250

Imelo:jymed@jymedtech.com

Address: Pansi 8 & 9, Building 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen